A new global headquarters for a leading material manufacturer was required which would encompass the repurposing of an existing 1960’s building frame. The project involved the reconfiguration and extension of the existing structure, providing processing and research facilities suited to Invibio’s biomaterial development activities. This includes a Class 10,000 pilot plant facility for the development of surgical implants, the provision of a 14 tonne injection moulding facility for the development of prototypes, as well as a new high-quality environment comprising of offices, research, and development facilities.
The intent for the new building was to create a visually impressive development that conforms to the technical nature of Invibio’s core business activities, creating an image that is compatible with the medical background of their client base. Wilson Mason worked closely with the client to ultimately deliver a sustainable and cost-effective solution.